The National Center for Chronic Disease Prevention and Health Promotion, 15327 [05-5913]

Download as PDF Federal Register / Vol. 70, No. 57 / Friday, March 25, 2005 / Notices 15327 TABLE 1.—FRAMEWORK FOR EQUIVALENT PROTECTIONS—Continued Specific protection Example procedures 45 CFR part 46 subpart A authority 46.111(a)(4) Informed consent will be sought from each prospective subject or the subject’s legally authorized representative, in accordance with, and to the extent required by § 46.116. 46.116(a)(1–8) Necessary elements of disclosure. 46.116(b)(1–6) Necessary elements of disclosure. 46.116(c)(1–2) Waiver of informed consent. 46.116(d)(1–4) Approval of alternate consent procedures or waiver. 46.117(a) Written informed consent. Bernard A. Schwetz, Director, Office for Human Research Protections. [FR Doc. 05–5947 Filed 3–24–05; 8:45 am] BILLING CODE 4150–36–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention The National Center for Chronic Disease Prevention and Health Promotion In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following meeting. Name: Interagency Committee on Smoking and Health. Time and Date: 9 a.m.–4:30 p.m., April 13, 2005. Place: Omni Shoreham Hotel, Hampton Ballroom, 2500 Calvert Street, NW., Washington, DC 20008. Telephone: 202–234– 0700. Status: Open to the public, limited only by the space available. Those who wish to attend are encouraged to register with the contact person listed below. If you will require a sign language interpreter, or have other special needs, please notify the contact person by 4:30 e.s.t. on April 4, 2005. Purpose: The Interagency Committee on Smoking and Health advises the Secretary, Department of Health and Human Services, and the Assistant Secretary for Health in the (a) coordination of all research and education programs and other activities within the Department and with other Federal, State, local and private agencies and (b) establishment and maintenance of liaison with appropriate private entities, Federal agencies, and State and local public health agencies with respect to smoking and health activities. Matters to be Discussed: The agenda will focus on addressing the Global Tobacco Epidemic. For Further Information Contact: Substantive program information as well as summaries of the meeting and roster of committee members may be obtained from the Internet at https://www.cdc.gov/tobacco in mid-May or from Ms. Monica L. Swann, Management and Program Analyst, Office on VerDate jul<14>2003 16:11 Mar 24, 2005 Jkt 205001 Smoking and Health, 200 Independence Avenue, SW., Suite 317B, Washington, DC 20201, (202) 205–8500. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 18, 2005. Alvin Hall, Director, Management Analysis and Service Office, Centers for Disease Control and Prevention. [FR Doc. 05–5913 Filed 3–24–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Infectious Diseases In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Name: Board of Scientific Counselors, National Center for Infectious Diseases (NCID). Times and Dates: 9 a.m.–5:30 p.m., May 12, 2005. 8:30 a.m.–2 p.m., May 13, 2005. Place: CDC, Auditorium B, Building 1, 1600 Clifton Road, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The Board of Scientific Counselors, NCID, provides advice and guidance to the Director, CDC, and Director, NCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities. Matters To Be Discussed: Agenda items will include: 1. Opening Session: NCID Update. 2. Futures Initiative Update. 3. Environmental Microbiology. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 4. Development of CDC Research Agenda. 5. Veterinary-Human Public Health Interface. 6. Global Disease Detection Initiative. 7. Topic Updates. a. Influenza. b. Chronic Wasting Disease. c. Quarantine Update. 8. Board meets with Director, CDC. Other agenda items include announcements/introductions; follow-up on actions recommended by the Board December 2004; consideration of future directions, goals, and recommendations. Agenda items are subject to change as priorities dictate. Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting. Contact Person for More Information: Tony Johnson, Office of the Director, NCID, CDC, Mailstop E–51, 1600 Clifton Road, NE., Atlanta, Georgia 30333, e-mail tjohnson3@cdc.gov; telephone 404/498–3249. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 18, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–5909 Filed 3–24–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–2211–N] Medicare, Medicaid, and CLIA Programs; Continuance of the Approval of the American Society for Histocompatibility and Immunogenetics as a CLIA Acreditation Organization Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: E:\FR\FM\25MRN1.SGM 25MRN1

Agencies

[Federal Register Volume 70, Number 57 (Friday, March 25, 2005)]
[Notices]
[Page 15327]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5913]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


The National Center for Chronic Disease Prevention and Health 
Promotion

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention announces the following meeting.

    Name: Interagency Committee on Smoking and Health.
    Time and Date: 9 a.m.-4:30 p.m., April 13, 2005.
    Place: Omni Shoreham Hotel, Hampton Ballroom, 2500 Calvert 
Street, NW., Washington, DC 20008. Telephone: 202-234-0700.
    Status: Open to the public, limited only by the space available. 
Those who wish to attend are encouraged to register with the contact 
person listed below. If you will require a sign language 
interpreter, or have other special needs, please notify the contact 
person by 4:30 e.s.t. on April 4, 2005.
    Purpose: The Interagency Committee on Smoking and Health advises 
the Secretary, Department of Health and Human Services, and the 
Assistant Secretary for Health in the (a) coordination of all 
research and education programs and other activities within the 
Department and with other Federal, State, local and private agencies 
and (b) establishment and maintenance of liaison with appropriate 
private entities, Federal agencies, and State and local public 
health agencies with respect to smoking and health activities.
    Matters to be Discussed: The agenda will focus on addressing the 
Global Tobacco Epidemic.
    For Further Information Contact: Substantive program information 
as well as summaries of the meeting and roster of committee members 
may be obtained from the Internet at https://www.cdc.gov/tobacco in 
mid-May or from Ms. Monica L. Swann, Management and Program Analyst, 
Office on Smoking and Health, 200 Independence Avenue, SW., Suite 
317B, Washington, DC 20201, (202) 205-8500.
    Agenda items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 18, 2005.
Alvin Hall,
Director, Management Analysis and Service Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-5913 Filed 3-24-05; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.